Risk Factors for High-Titer Inhibitor Development in Children with Hemophilia A: Results of a Cohort Study

Among the discussed risk factors for high-titre inhibitor (HRI) development in patients with hemophilia A (HA) are high dose FVIII replacement therapy and use of recombinant FVIII concentrates (rFVIII). The aim of this study was to evaluate the aforementioned risk factors for HRI development in chil...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Halimeh, Susan, Bidlingmaier, Christoph, Heller, Christine, Gutsche, Sven, Holzhauer, Susanne, Kenet, Gili, Kurnik, Karin, Manner, Daniela, Iorio, Alfonso, Nowak-Göttl, Ulrike
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Hindawi Publishing Corporation 2013
Onderwerpen:
Clinical Study
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3807559/
https://ncbi.nlm.nih.gov/pubmed/24199202
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/901975
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items